Last updated 2026-07-20
- Acquired by Notable Labs, Inc. for $145M, Oct 2023
- Raised $40M Undisclosed Round led by Pitango VC, Sep 2010
- Raised $16.9M PIPE led by EIC Accelerator, Nov 2021
Total raised
$59.8M
Last: Grant 2021-12
Stage
Public
Founded
2000
Headcount
30
HQ
Modi'in-Maccabim-Re'ut, Israel
Sector
Health Tech & Life Sciences
About
VBL Therapeutics was a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class treatments for cancer and immune-inflammatory indications. The company's lead oncology product candidate, ofranergene obadenovec (VB-111), was a gene-therapy based agent. VBL also developed programs based on its novel biological findings related to the MOSPD2 protein and Lecinoxoids, a class of anti-inflammatory small molecules.
Funding history · 5 rounds · $59.8M total
2021-11
Grant
$2.8M
2021-11
PIPE
$16.9M
★ EIC Accelerator
2020-04
Follow-on PO
Undisclosed
2014-09
Follow-on PO
Undisclosed
2010-09
Undisclosed Round
$40.0M
★ Pitango VC★ Max Herzberg★ GlenRock Group★ Kadima High Tech★ Aurum Ventures M.K.I★ Merck Global Health Innovation Fund★ Teva Pharmaceuticals' RISE Challenge
Headcount over time
From 21 (2018-09) to 13 (2025-12) · -8 (-38%) · 39 points · source: Finder history + radar grounding
Q&A
- What is VBL Therapeutics' current status?
- VBL Therapeutics was acquired by Notable Labs in February 2023.
- What is VBL Therapeutics' primary focus?
- VBL Therapeutics focuses on targeted therapies for immune-inflammatory diseases, utilizing its Monocyte Targeting Technology (MTT) to limit chronic inflammation.
- What is the name of VBL Therapeutics' lead MTT candidate?
- The company's lead MTT candidate is VB-601, an investigational proprietary monoclonal antibody designed to block monocytes from reaching inflamed tissues.
- What is the total amount of funding VBL Therapeutics has raised?
- VBL Therapeutics has raised a total of $109,770,000 in funding.
- When did VBL Therapeutics receive its most recent grant?
- VBL Therapeutics received a grant of $2,820,000 in December 2021 from the EIC Accelerator Programme.
- Which investors participated in VBL Therapeutics' October 2010 funding round?
- In October 2010, VBL Therapeutics received funding from investors including.
- How many employees does VBL Therapeutics have?
- VBL Therapeutics has 11-50 employees.
- What is VBL Therapeutics' primary sector?
- VBL Therapeutics' primary sector is Health Tech & Life Sciences.
Team · 1
Prof. Dror Harats, M.D.
Founder · Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
biotechnologyinflammatory-diseasesdrug-discoverybiopharmaceuticaloncologycancer-therapypharma-companiescancertreatmentsbioconvergence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | vblrx.com |
|---|---|
| linkedin.com/company/6282834 | |
| facebook.com/VascularBiogenics | |
| YouTube | youtube.com/channel/UCH7FqeGIzXzvTKsqxWNy6-w |
Identifiers & details
| Legal name | Vascular Biogenics Ltd. |
|---|---|
| Founded | 2000-1 |
| Employees (exact) | 30 |
| Market cap | $16.2M |
| Status reason | Acquired by Notable Labs on Feb, 2023 |
Acquisitions & public offerings
Acquired by Notable Labs, Inc. 2023-10 $145.0M
Radar intelligence
Web history (Wayback)
| Domain | vblrx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 512899766 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה ציבורית |
| Incorporated | 2000-01-31 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2022 |
| Active charges / liens | 0 |
| Registry events | 1 — other (1) |
| Registered address | דרך אבא הלל 16 רמת גן |
Recent registry events
| Date | Event |
|---|---|
| 2025-12-15 | עדכון חיובים במג~ק |